Axsome Therapeutics Announces Positive Outcome of Interim Analysis of STRIDE-1 Phase 3 Trial of AXS-05 Pharmaceutical Investing
Merus Announces Recent Corporate Developments and Financial Results for the Fourth Quarter and Full Year 2017 Biotech Investing
Eloxx Pharmaceuticals Announces Uplisting to Nasdaq and Pricing of $50 Million Public Offering of Common Stock Pharmaceutical Investing
FDA Determines that Afrezza REMS Communication Plan Has Met Goals and REMS No Longer Necessary Pharmaceutical Investing
Canntab Therapeutics Files 11 Patent Applications Related to Pharmaceutical Cannabis Cannabis Investing News
Xanthic Biopharma Inc. President, Gary Galitsky and Board Member, Dr. Gunther Hintz, Advance Cannabis Opportunity In Thailand Cannabis Investing News
Isodiol Receives Government Approval for Pure, Natural CBD as an Active Pharmaceutical Ingredient Cannabis Investing News
Alder BioPharmaceuticals® New Data Demonstrated Eptinezumab Increased Migraine-Free Intervals and Improved Quality-of-Life Outcomes in Patients with Episodic Migraine Pharmaceutical Investing
BriaCell and BriaPro to Present Preclinical Anti-Cancer Activity and Immunotherapy Findings at SITC 2026Â
